Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It is part of the GLP-1 receptor agonist drug class and was one of the earliest GLP-1 drugs approved specifically for obesity treatment
M.BozzaP
has received honoraria for lectures sponsored by Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity Gastroenterology 163(5) 2022PMID: 36273831 PubMed References open in a new tab
US$ 27.24
-1781043799568.png&w=3840&q=75)
US$ 22.22
US$ 26.26
US$ 26.64
US$ 22.17
US$ 27.16
US$ 26.51
US$ 24.31
US$ 27.69
US$ 25.93
US$ 22.05
US$ 25.21
US$ 21.03
US$ 27.68
US$ 24.89
US$ 24.03
